GIKLY News and Press, Grifols SA ADR

2026-07-03 10:49:07 ET We are back to comment on Grifols, S.A. ( GRFS ), following the many latest changes since our last update (December 2025). We provided an equal-weight rating due to delayed product catalysts and elevated leverage. This proved to be the right call (Fig. 1),...

2026-05-09 15:31:13 ET Grifols, S.A. (GIKLY) Q1 2026 Earnings Call May 7, 2026 12:30 PM EDT Company Participants Daniel Segarra - Head of Investor Relations & Sustainability and Vice President Jose Ignacio Abia Buenache - CEO & Director Roland Wandeler - Pr...

2026-03-30 09:17:55 ET Since my article , "My Top 5 Biotech Stocks Big Pharma Could Buy Next," Kamada shares ( KMDA ) have risen 22.4%, outperforming the so-called "bellwether" for the biotech investors, the iShares Biotechnology ETF [6.5% return] ( IBB ), as well as the S&a...

2026-03-11 21:36:20 ET Grifols ( GRFS ) is a company that I've covered for a while - at times it's gone up, at times my position is down, but usually safe (as I believe the company is now). Before this article, I went back and forth as to whether to make the company a 'speculative' ...

2026-03-03 15:20:30 ET More on Spanish stocks Banco Santander, S.A. (SAN) Analyst/Investor Day Transcript Banco Santander: The Risk-Reward Proposition Has Not Improved Much Following Recent Events Grifols, S.A. (GIKLY) Q4 2025 Earnings Call Transcript Webster...

2026-02-26 17:27:54 ET Grifols, S.A. (GIKLY) Q4 2025 Earnings Call February 26, 2026 12:30 PM EST Company Participants Daniel Segarra - Head of Investor Relations & Sustainability and Vice President Jose Ignacio Abia Buenache - CEO & Director Roland Wandele...

2026-01-26 21:15:00 ET The following segment was excerpted from the White Falcon Capital Q4 And FY 2025 Partner Letter. ... Read the full article on Seeking Alpha For further details see: White Falcon: Q4 2025 Portfolio Positions

2025-12-08 12:02:09 ET I've been a frequent analyst for covering Grifols, S.A. ( GRFS ) as a business here on Seeking Alpha. The world's largest blood plasma business, with other adjacent/related businesses, is going through a renaissance, rising like a phoenix from the ashes of wha...

2025-11-05 16:11:15 ET Grifols, S.A. (GIKLY) Q3 2025 Earnings Call November 4, 2025 12:30 PM EST Company Participants Daniel Segarra - Head of Investor Relations & Sustainability and Vice President Jose Ignacio Abia Buenache - CEO & Director Roland Wandeler...

2025-10-06 13:29:00 ET On September 17 , the Fed began cutting interest rates again, which historically preceded Big Pharma's increased activity in the M&A space.... Read the full article on Seeking Alpha For further details see: My Top 5 Biotech Stocks Big Pharm...